Twinlab Consolidated Holdings Stock Performance

TLCC Stock  USD 0.0004  0.0002  33.33%   
The entity has a beta of -0.35, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Twinlab Consolidated are expected to decrease at a much lower rate. During the bear market, Twinlab Consolidated is likely to outperform the market. At this point, Twinlab Consolidated has a negative expected return of -0.53%. Please make sure to validate Twinlab Consolidated's maximum drawdown, as well as the relationship between the rate of daily change and price action indicator , to decide if Twinlab Consolidated performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Twinlab Consolidated Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Begin Period Cash Flow424 K
Total Cashflows From Investing Activities-155 K
  

Twinlab Consolidated Relative Risk vs. Return Landscape

If you would invest  0.06  in Twinlab Consolidated Holdings on November 9, 2025 and sell it today you would lose (0.02) from holding Twinlab Consolidated Holdings or give up 33.33% of portfolio value over 90 days. Twinlab Consolidated Holdings is currently does not generate positive expected returns and assumes 4.1996% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of pink sheets are less volatile than Twinlab, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Twinlab Consolidated is expected to under-perform the market. In addition to that, the company is 5.13 times more volatile than its market benchmark. It trades about -0.13 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Twinlab Consolidated Target Price Odds to finish over Current Price

The tendency of Twinlab Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0004 90 days 0.0004 
close to 99
Based on a normal probability distribution, the odds of Twinlab Consolidated to move above the current price in 90 days from now is close to 99 (This Twinlab Consolidated Holdings probability density function shows the probability of Twinlab Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Twinlab Consolidated Holdings has a beta of -0.35. This usually implies as returns on the benchmark increase, returns on holding Twinlab Consolidated are expected to decrease at a much lower rate. During a bear market, however, Twinlab Consolidated Holdings is likely to outperform the market. Additionally Twinlab Consolidated Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Twinlab Consolidated Price Density   
       Price  

Predictive Modules for Twinlab Consolidated

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Twinlab Consolidated. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Twinlab Consolidated's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00044.20
Details
Intrinsic
Valuation
LowRealHigh
0.000.00044.20
Details
Naive
Forecast
LowNextHigh
0.0000060.00034.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00060.00060.0006
Details

Twinlab Consolidated Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Twinlab Consolidated is not an exception. The market had few large corrections towards the Twinlab Consolidated's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Twinlab Consolidated Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Twinlab Consolidated within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.49
β
Beta against Dow Jones-0.35
σ
Overall volatility
0.000042
Ir
Information ratio -0.14

Twinlab Consolidated Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Twinlab Consolidated for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Twinlab Consolidated can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Twinlab Consolidated generated a negative expected return over the last 90 days
Twinlab Consolidated has some characteristics of a very speculative penny stock
Twinlab Consolidated has high historical volatility and very poor performance
Twinlab Consolidated has a very high chance of going through financial distress in the upcoming years
Twinlab Consolidated Holdings currently holds 102.97 M in liabilities with Debt to Equity (D/E) ratio of 5.29, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Twinlab Consolidated has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Twinlab Consolidated until it has trouble settling it off, either with new capital or with free cash flow. So, Twinlab Consolidated's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Twinlab Consolidated sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Twinlab to invest in growth at high rates of return. When we think about Twinlab Consolidated's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 72.09 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 16.58 M.
About 82.0% of Twinlab Consolidated outstanding shares are owned by corporate insiders

Twinlab Consolidated Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Twinlab Pink Sheet often depends not only on the future outlook of the current and potential Twinlab Consolidated's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Twinlab Consolidated's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding258.8 M
Cash And Short Term Investments3.6 M

Twinlab Consolidated Fundamentals Growth

Twinlab Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Twinlab Consolidated, and Twinlab Consolidated fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Twinlab Pink Sheet performance.

About Twinlab Consolidated Performance

By analyzing Twinlab Consolidated's fundamental ratios, stakeholders can gain valuable insights into Twinlab Consolidated's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Twinlab Consolidated has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Twinlab Consolidated has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida. Twinlab Consolidated operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 62 people.

Things to note about Twinlab Consolidated performance evaluation

Checking the ongoing alerts about Twinlab Consolidated for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Twinlab Consolidated help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Twinlab Consolidated generated a negative expected return over the last 90 days
Twinlab Consolidated has some characteristics of a very speculative penny stock
Twinlab Consolidated has high historical volatility and very poor performance
Twinlab Consolidated has a very high chance of going through financial distress in the upcoming years
Twinlab Consolidated Holdings currently holds 102.97 M in liabilities with Debt to Equity (D/E) ratio of 5.29, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Twinlab Consolidated has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Twinlab Consolidated until it has trouble settling it off, either with new capital or with free cash flow. So, Twinlab Consolidated's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Twinlab Consolidated sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Twinlab to invest in growth at high rates of return. When we think about Twinlab Consolidated's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 72.09 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 16.58 M.
About 82.0% of Twinlab Consolidated outstanding shares are owned by corporate insiders
Evaluating Twinlab Consolidated's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Twinlab Consolidated's pink sheet performance include:
  • Analyzing Twinlab Consolidated's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Twinlab Consolidated's stock is overvalued or undervalued compared to its peers.
  • Examining Twinlab Consolidated's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Twinlab Consolidated's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Twinlab Consolidated's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Twinlab Consolidated's pink sheet. These opinions can provide insight into Twinlab Consolidated's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Twinlab Consolidated's pink sheet performance is not an exact science, and many factors can impact Twinlab Consolidated's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Twinlab Pink Sheet analysis

When running Twinlab Consolidated's price analysis, check to measure Twinlab Consolidated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twinlab Consolidated is operating at the current time. Most of Twinlab Consolidated's value examination focuses on studying past and present price action to predict the probability of Twinlab Consolidated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twinlab Consolidated's price. Additionally, you may evaluate how the addition of Twinlab Consolidated to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges